At a glance
ClinicalIndex Comparison RecordN/ACompleted· 73 enrolled
Drug / intervention
Thiamindrug
Likely dose
Thiamin 200 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Impact of Thiamine Supplementation on Clinical Outcomes of Patients With Septic Shock: a Retrospective Before-after Study
In Brief
An observational study evaluating Thiamin for Septic Shock. Completed, enrolled 73 participants across 2 sites.
Detailed Summary
This controlled before-and-after study analyse the impact of thiamine supplementation on outcomes of patients with septic shock treated according to the surviving sepsis campaign 2021 guidelines
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsSeptic Shock
CountriesBrazil
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedMay 2023
Enrollment StartSep 2023
Primary CompletionNov 2023
Study CompletionDec 2023
TodayJul 2026
First PostedMay 3, 2023
Enrollment StartSep 1, 2023
Primary CompletionNov 30, 2023
Study CompletionDec 31, 2023
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 3.2 years ago
Interventions
Thiamindrug
Patients in thiamine group received two daily dosis of 200 mg of thiamin diluted in 50 ml of 5% dextrose during 7 days